These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 9520085)
1. Localization of galectin-3 in normal and diseased pancreatic tissue. Schaffert C; Pour PM; Chaney WG Int J Pancreatol; 1998 Feb; 23(1):1-9. PubMed ID: 9520085 [TBL] [Abstract][Full Text] [Related]
2. Blood-group antigen expression during pancreatic cancer induction in hamsters. Pour PM; Uchida E; Burnett DA; Steplewski Z Int J Pancreatol; 1986 Dec; 1(5-6):327-40. PubMed ID: 3316427 [TBL] [Abstract][Full Text] [Related]
3. Subcellular localization of blood group A substance produced by pancreatic adenocarcinoma induced in hamsters by N-nitrosobis(2-oxopropyl)amine (BOP) and by its cell line (PC-1). Egami H; Chaney WG; Takiyama Y; Pour PM Carcinogenesis; 1991 Mar; 12(3):509-14. PubMed ID: 1672628 [TBL] [Abstract][Full Text] [Related]
4. Cellular and subcellular localization of transforming growth factor-alpha and epidermal growth factor receptor in normal and diseased human and hamster pancreas. Tomioka T; Toshkov I; Kazakoff K; Andrén-Sandberg A; Takahashi T; Büchler M; Friess H; Vaughn R; Pour PM Teratog Carcinog Mutagen; 1995; 15(5):231-50. PubMed ID: 8867879 [TBL] [Abstract][Full Text] [Related]
5. Increased expression of inducible nitric oxide synthase (iNOS) in N-nitrosobis(2-oxopropyl)amine-induced hamster pancreatic carcinogenesis and prevention of cancer development by ONO-1714, an iNOS inhibitor. Takahashi M; Kitahashi T; Ishigamori R; Mutoh M; Komiya M; Sato H; Kamanaka Y; Naka M; Maruyama T; Sugimura T; Wakabayashi K Carcinogenesis; 2008 Aug; 29(8):1608-13. PubMed ID: 18567618 [TBL] [Abstract][Full Text] [Related]
6. Stimulation of islet cell proliferation enhances pancreatic ductal carcinogenesis in the hamster model. Pour PM; Kazakoff K Am J Pathol; 1996 Sep; 149(3):1017-25. PubMed ID: 8780405 [TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 expression in hamster and human pancreatic neoplasia. Crowell PL; Schmidt CM; Yip-Schneider MT; Savage JJ; Hertzler DA; Cummings WO Neoplasia; 2006 Jun; 8(6):437-45. PubMed ID: 16820089 [TBL] [Abstract][Full Text] [Related]
8. Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma. Masaki Y; Oka M; Ogura Y; Ueno T; Nishihara K; Tangoku A; Takahashi M; Yamamoto M; Irimura T Hepatogastroenterology; 1999; 46(28):2240-5. PubMed ID: 10521973 [TBL] [Abstract][Full Text] [Related]
9. Modification of pancreatic carcinogenesis in the hamster model. 2. The effect of partial pancreatectomy. Pour PM; Donnelly T; Stepan K; Muffly K Am J Pathol; 1983 Jan; 110(1):75-82. PubMed ID: 6295175 [TBL] [Abstract][Full Text] [Related]
10. Expression of human tumor-associated antigens in pancreatic cancer induced in Syrian hamsters. Takiyama Y; Egami H; Pour PM Am J Pathol; 1990 Mar; 136(3):707-15. PubMed ID: 2316628 [TBL] [Abstract][Full Text] [Related]
11. In vitro induction of giant cell tumors from cultured hamster islets treated with N-Nitrosobis(2-Oxopropyl)amine. Matsuzaki H; Schmied BM; Ulrich A; Batra SK; Pour PM Am J Pathol; 2000 Feb; 156(2):439-43. PubMed ID: 10666373 [TBL] [Abstract][Full Text] [Related]
12. Augmentation of carcinogenesis by N-nitrosobis(2-oxopropyl)amine administered during S phase of the cell cycle in regenerating hamster pancreas. Scarpelli DG; Rao MS; Subbarao V Cancer Res; 1983 Feb; 43(2):611-6. PubMed ID: 6848182 [TBL] [Abstract][Full Text] [Related]
13. Modification of blood group A expression in human pancreatic tumor cell lines by inhibitors of N-glycan processing. Schaffert C; Pour PM; Chaney WG Int J Pancreatol; 1997 Feb; 21(1):21-9. PubMed ID: 9127170 [TBL] [Abstract][Full Text] [Related]
14. Modification of pancreatic carcinogenesis in the hamster model. 6. The effect of ductal ligation and excision. Pour PM; Donnelly T; Stepan K Am J Pathol; 1983 Dec; 113(3):365-72. PubMed ID: 6650665 [TBL] [Abstract][Full Text] [Related]
15. Expression of endogenous galectin-1 and galectin-3 in intrahepatic cholangiocarcinoma. Shimonishi T; Miyazaki K; Kono N; Sabit H; Tuneyama K; Harada K; Hirabayashi J; Kasai K; Nakanuma Y Hum Pathol; 2001 Mar; 32(3):302-10. PubMed ID: 11274640 [TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer. Berberat PO; Friess H; Wang L; Zhu Z; Bley T; Frigeri L; Zimmermann A; Büchler MW J Histochem Cytochem; 2001 Apr; 49(4):539-49. PubMed ID: 11259457 [TBL] [Abstract][Full Text] [Related]
17. Evolution of the expression of fetal acinar antigens during carcinogenesis of the pancreas in hamsters: individual follow-up by open biopsy. Eriguchi M; Carré-Llopis A; Orbach-Arbouys S; Escribano J J Natl Cancer Inst; 1987 Mar; 78(3):519-25. PubMed ID: 3469464 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of streptozotocin-induced islet cell tumors and N-nitrosobis(2-oxopropyl)amine-induced pancreatic exocrine tumors in Syrian hamsters by exogenous insulin. Pour PM; Kazakoff K; Carlson K Cancer Res; 1990 Mar; 50(5):1634-9. PubMed ID: 2154330 [TBL] [Abstract][Full Text] [Related]
19. Expression of Oct4, a stem cell marker, in the hamster pancreatic cancer model. Iki K; Pour PM Pancreatology; 2006; 6(4):406-13. PubMed ID: 16809941 [TBL] [Abstract][Full Text] [Related]
20. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions. Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]